Skip to main content

DNA Vaccination for Prostate Cancer

  • Protocol
Electroporation Protocols

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 423))

Abstract

DNA-based cancer vaccines have been used successfully in mice to induce cytotoxic T lymphocytes (CTLs) specific for prostate antigens. Translation of a prostate-specific antigen (PSA) DNA vaccine into a phase I clinical trial demonstrated that PSA-specific immune responses could be induced but at a significantly lower level compared with those in mice. To enhance the efficacy of DNA vaccination against prostate cancer, we have explored and optimized intradermal electroporation as an effective way of delivering a PSA DNA vaccine. The results demonstrated that intradermal DNA vaccination using low amounts of DNA, followed by two sets of electrical pulses of different length and voltage, effectively induced PSA-specific T cells. Here we describe in detail how to perform intradermal DNA electroporation to induce high gene expression in skin and, more important, how to induce and analyze PSA-specific T cell responses.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. 1. Ferlay, J., Bray, F., Pisani, P., and Parkin, D.M. (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase. IARC Press, Lyon.

    Google Scholar 

  2. 2. Pavlenko, M., Roos, A.K., Leder, C., et al. (2004) Comparison of PSA-specific CD8+ CTL responses and antitumor immunity generated by plasmid DNA vaccines encoding PSA-HSP chimeric proteins. Cancer Immunol. Immunother. 53, 1085–1092.

    Article  CAS  PubMed  Google Scholar 

  3. 3. Roos, A.K., Pavlenko, M., Charo, J., Egevad, L., and Pisa, P. (2005) Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine. Prostate. 62, 217–223.

    Article  CAS  PubMed  Google Scholar 

  4. 4. Pavlenko, M., Roos, A.K., Lundqvist, A., et al. (2004) A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer. Br. J. Cancer. 91, 688–694.

    CAS  PubMed  Google Scholar 

  5. 5. Draghia-Akli, R., Khan, A.S., Pope, M.A., and Brown, P.A. (2005) Innovative electroporation for therapeutic and vaccination applications. Gene Ther. Mol. Biol. 9, 329–338.

    Google Scholar 

  6. 6. Otten, G., Schaefer, M., Doe, B., et al. (2004) Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Vaccine. 22, 2489–2493.

    Article  CAS  PubMed  Google Scholar 

  7. 7. Babiuk, S., Baca-Estrada, M.E., Foldvari, M., et al. (2002) Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine. 20, 3399–3408.

    Article  CAS  PubMed  Google Scholar 

  8. 8. Prud'homme, G.J., Glinka, Y., Khan, A.S., and Draghia-Akli, R. (2006) Electroporation-enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases. Curr. Gene Ther. 6, 243–273.

    Article  PubMed  Google Scholar 

  9. 9. Corr, M., von Damm, A., Lee, D.J., and Tighe, H. (1999) In vivo priming by DNA injection occurs predominantly by antigen transfer. J. Immunol. 163, 4721–4727.

    CAS  PubMed  Google Scholar 

  10. 10. Cho, J.H., Youn, J.W., and Sung, Y.C. (2001) Cross-priming as a predominant mechanism for inducing CD8(+) T cell responses in gene gun DNA immunization. J. Immunol. 167, 5549–5557.

    CAS  PubMed  Google Scholar 

  11. 11. Peachman, K.K., Rao, M., and Alving, C.R. (2003) Immunization with DNA through the skin. Methods. 31, 232–242.

    Article  CAS  PubMed  Google Scholar 

  12. 12. Roos, A.K., Moreno, S., Leder, C., Pavlenko, M., King, A., and Pisa, P. (2006) Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation. Mol. Ther. 13, 320–327.

    Article  CAS  PubMed  Google Scholar 

  13. 13. Pavlenko, M., Leder, C., Roos, A.K., Levitsky, V., and Pisa, P. (2005) Identification of an immunodominant H-2D(b)-restricted CTL epitope of human PSA. Prostate. 64, 50–59.

    Article  CAS  PubMed  Google Scholar 

  14. 14. Heller, R., Jaroszeski, M., Atkin, A., et al. (1996) In vivo gene electroinjection and expression in rat liver. FEBS Lett. 389, 225–228.

    Article  CAS  PubMed  Google Scholar 

  15. 15. Heller, R., Jaroszeski, M.J., Reintgen, D.S., et al. (1998) Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer. 83, 148–157.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press

About this protocol

Cite this protocol

Roos, AK., King, A., Pisa, P. (2008). DNA Vaccination for Prostate Cancer. In: Li, S. (eds) Electroporation Protocols. Methods in Molecular Biology™, vol 423. Humana Press. https://doi.org/10.1007/978-1-59745-194-9_36

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-194-9_36

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-877-5

  • Online ISBN: 978-1-59745-194-9

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics